- Pharmaceuticals: Interactive cost-utility Markov-Microsimulation model (MCMC) with Excel®, pathology: Venous leg ulcer. Interactive budget impact model with Excel®
- Pharmaceuticals: Interactive cost-utility Markov model with Excel®, pathology: Severe aortic stenosis (SAS).
- Pharmaceuticals: Bayesian multi-treatment meta-analysis with Winbugs/R, pathology: Severe aortic stenosis (SAS).
Book: Robert Launois1, Elise Meto1, Elise Cabout1, Franck Maunoury2,3. Medico-Economic Evaluation in Health Care: Methods and Practices. ESKA. Paris (2025). 1 REES France, Paris, France; 2 Le Mans Université, GAINS, IRA, Le Mans, France; 3 STATESIA, Le Mans, France. 387 p. ISBN 978-2-7472-3643-0.
May 2023. Early meetings with HAS-DEAI: Haute Autorité de Santé (HAS, DEAI), Paris.
"Presentation of cost-effectiveness and budget impact models in patients with myocardial infarction".
PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE.
F. Maunoury1, C. Pribil2, M. Aubier3, G. Nachbaur2, S. Doyle4
1 STATESIA, Le Mans, France; 2 GlaxoSmithKline, RueilMalmaison, France; 3 Bichat University Hospital, Paris, France; 4 GlaxoSmithKline, London, UK
